An in-depth analysis of 2024’s global deal-making trends across biopharma and medtech. From billion-dollar alliances to resurgent financing and shifting M&A dynamics, this report unpacks the year’s biggest moves, top therapeutic areas, and standout transactions as tracked by Biomedtracker.